CSF2 and pulmonary alveolar proteinosis: As shown in Table 5, the most frequently cited article was published by Bruce C Trapnell in NEJM in 2003 (15), which reports that GM-CSF autoantibodies are markedly elevated in autoimmune PAP but not in patients with secondary PAP, congenital PAP, other lung diseases, or healthy people.